Target Interacting Protein Information
Target General Information | Top | ||||
---|---|---|---|---|---|
Target ID | T80423 | Target Info | |||
Target Name | von Hippel-Lindau disease tumor suppressor (VHL) | ||||
Synonyms | pVHL; Protein G7 | ||||
Target Type | Patented-recorded Target | ||||
Gene Name | VHL | ||||
UniProt ID |
Target Interacting Proteins | Top | ||||
---|---|---|---|---|---|
Actins | [+] 1 Actins | + | |||
Interacting Protein Name | Beta-actin (ACTB) | Interacting Protein | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | BRWS1; PS1TP5BP1 | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Affinity Capture-MS | [1] | |||
2 | Reconstituted Complex | [2] | |||
Acyltransferases | [+] 2 Acyltransferases | + | |||
Interacting Protein Name | E3 ubiquitin-protein ligase RBX1 (RBX1) | Interacting Protein | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | BA554C12.1; RNF75; ROC1 | ||||
Evidence Score (E-score) | 10 Experimental Evidences | + | |||
1 | Affinity Capture-MS | [3] | |||
2 | Affinity Capture-MS | [4] | |||
3 | Affinity Capture-MS | [5] | |||
4 | Affinity Capture-Western | [6] | |||
5 | Affinity Capture-Western | [7] | |||
6 | Affinity Capture-Western | [8] | |||
7 | Affinity Capture-Western | [9] | |||
8 | Affinity Capture-Western | [10] | |||
9 | Affinity Capture-Western | [11] | |||
10 | Co-purification | [12] | |||
Interacting Protein Name | E3 SUMO-protein ligase PIAS4 (PIAS4) | Interacting Protein | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | PIASY; Piasg; ZMIZ6 | ||||
Evidence Score (E-score) | 3 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [13] | |||
2 | Affinity Capture-Western | [14] | |||
3 | Reconstituted Complex | [14] | |||
Carbon-nitrogen hydrolases | [+] 2 Carbon-nitrogen hydrolases | + | |||
Interacting Target Name | Histone deacetylase 1 (HDAC1) | Successful Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | RPD3L1; HD1 | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [15] | |||
2 | Reconstituted Complex | [16] | |||
Interacting Target Name | Histone deacetylase 2 (HDAC2) | Clinical trial Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | HD2 | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [15] | |||
2 | Reconstituted Complex | [16] | |||
Cell cycle related proteins | [+] 1 Cell cycle related proteins | + | |||
Interacting Target Name | Multiple tumor suppressor 1 (CDKN2A) | Literature-reported Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | Tumour suppressor gene p16; P16-INK4a; p16INK4A; P16-INK4; P16 gene; MTS-1; Cyclin-dependent kinase inhibitor 2A; Cyclin-dependent kinase 4 inhibitor A; CDK4I | ||||
Evidence Score (E-score) | 3 Experimental Evidences | + | |||
1 | Affinity Capture-MS | [1] | |||
2 | Co-fractionation | [17] | |||
3 | Yeast two hybrid | [18] | |||
Cullins | [+] 1 Cullins | + | |||
Interacting Protein Name | Cullin-2 (CUL2) | Interacting Protein | Interacting Protein Info | ||
UniProt ID | |||||
Evidence Score (E-score) | 20 Experimental Evidences | + | |||
1 | Affinity Capture-MS | [19] | |||
2 | Affinity Capture-MS | [4] | |||
3 | Affinity Capture-MS | [3] | |||
4 | Affinity Capture-MS | [1] | |||
5 | Affinity Capture-MS | [20] | |||
6 | Affinity Capture-MS | [21] | |||
7 | Affinity Capture-MS | [22] | |||
8 | Affinity Capture-MS | [5] | |||
9 | Affinity Capture-MS | [23] | |||
10 | Affinity Capture-Western | [8] | |||
11 | Affinity Capture-Western | [24] | |||
12 | Affinity Capture-Western | [25] | |||
13 | Affinity Capture-Western | [26] | |||
14 | Affinity Capture-Western | [7] | |||
15 | Affinity Capture-Western | [27] | |||
16 | Affinity Capture-Western | [28] | |||
17 | Affinity Capture-Western | [29] | |||
18 | Affinity Capture-Western | [2] | |||
19 | Affinity Capture-Western | [23] | |||
20 | Affinity Capture-Western | [30] | |||
Heat shock proteins | [+] 1 Heat shock proteins | + | |||
Interacting Target Name | Lipopolysaccharide-associated protein 1 (HSPA8) | Literature-reported Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | LPS-associated protein 1; LAP-1; HSPA10; HSP73; HSC70; Heat shock protein 73; Heat shock cognate 71 kDa protein; Heat shock 70 kDa protein 8 | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Affinity Capture-MS | [1] | |||
2 | Reconstituted Complex | [2] | |||
Kinases | [+] 4 Kinases | + | |||
Interacting Protein Name | DNA-directed RNA polymerase II subunit RPB1 (POLR2A) | Interacting Protein | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | POLR2; POLRA; RPB1; RPBh1; RPO2; RPOL2; RpIILS; hRPB220; hsRPB1 | ||||
Evidence Score (E-score) | 4 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [31] | |||
2 | Affinity Capture-Western | [23] | |||
3 | Affinity Capture-Western | [10] | |||
4 | Protein-peptide | [10] | |||
Interacting Target Name | Aurora kinase A (AURKA) | Clinical trial Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | STK6; STK15; Serine/threonine-protein kinase aurora-A; Serine/threonine-protein kinase 6; Serine/threonine-protein kinase 15; Serine/threonine kinase 15; IAK1; hARK1; BTAK; Breast tumor-amplified kinase; AYK1; Aurora-related kinase 1; Aurora-A; Aurora/IPL1-related kinase 1; Aurora 2; AURA; ARK-1; ARK1; AIRK1; AIK | ||||
Evidence Score (E-score) | 3 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [32] | |||
2 | Affinity Capture-Western | [33] | |||
3 | Biochemical Activity | [33] | |||
Interacting Target Name | Casein kinase II alpha (CSNK2A1) | Clinical trial Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | Protein kinase CK2; CK2A1; CK II alpha; CK II; Casein kinase II subunit alpha | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [34] | |||
2 | Biochemical Activity | [34] | |||
Interacting Target Name | Protein kinase C delta (PRKCD) | Clinical trial Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | Tyrosine-protein kinase PRKCD; SDK1; Protein kinase C delta type catalytic subunit; Protein kinase C delta type; Protein Kinase C delta; PKC-delta; nPKC-delta | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [35] | |||
2 | Fluorescence Resonance Energy Transfer | [36] | |||
Lyases | [+] 1 Lyases | + | |||
Interacting Protein Name | Small ribosomal subunit protein uS3 (RPS3) | Interacting Protein | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | S3 | ||||
Evidence Score (E-score) | 3 Experimental Evidences | + | |||
1 | Affinity Capture-MS | [1] | |||
2 | Affinity Capture-Western | [37] | |||
3 | Co-fractionation | [37] | |||
Nuclear hormone receptors | [+] 1 Nuclear hormone receptors | + | |||
Interacting Target Name | Androgen receptor (AR) | Successful Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | Testosterone receptor; Nuclear receptor subfamily 3 group C member 4; NR3C4; Dihydrotestosterone receptor; DHTR; Androgen receptor | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [38] | |||
2 | Reconstituted Complex | [39] | |||
Oxidoreductases | [+] 1 Oxidoreductases | + | |||
Interacting Target Name | HIF-prolyl hydroxylase 2 (HPH-2) | Patented-recorded Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | SM-20; SM20; Prolyl hydroxylase domain-containing protein 2; Prolyl hydroxylase domaincontaining protein 2; PNAS-137; PNAS-118; PHD2; Hypoxia-inducible factor prolyl hydroxylase 2; Hypoxiainducible factor prolyl hydroxylase 2; HPH2; HIFprolyl hydroxylase 2; HIF-PH2; HIFPH2; Egl nine homolog 1; C1orf12 | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [40] | |||
2 | Reconstituted Complex | [41] | |||
Peptidases | [+] 1 Peptidases | + | |||
Interacting Target Name | VHL-interacting deubiquitinating enzyme 1 (VDU1) | Patented-recorded Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | Ubiquitin-specific-processing protease 33; Ubiquitin thioesterase 33; Ubiquitin carboxyl-terminal hydrolase 33; KIAA1097; hVDU1; Deubiquitinating enzyme 33 | ||||
Evidence Score (E-score) | 6 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [42] | |||
2 | Affinity Capture-Western | [43] | |||
3 | Biochemical Activity | [42] | |||
4 | Reconstituted Complex | [42] | |||
5 | Yeast two hybrid | [42] | |||
6 | Yeast two hybrid | [43] | |||
Pore-forming toxins | [+] 1 Pore-forming toxins | + | |||
Interacting Target Name | Cellular tumor antigen p53 (TP53) | Clinical trial Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | Tumor suppressor p53; Phosphoprotein p53; P53; Antigen NY-CO-13 | ||||
Evidence Score (E-score) | 4 Experimental Evidences | + | |||
1 | Affinity Capture-MS | [1] | |||
2 | Affinity Capture-Western | [44] | |||
3 | Affinity Capture-Western | [1] | |||
4 | Reconstituted Complex | [44] | |||
Ribosomal proteins | [+] 2 Ribosomal proteins | + | |||
Interacting Protein Name | Small ribosomal subunit protein uS8 (RPS15A) | Interacting Protein | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | S15a | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Affinity Capture-MS | [1] | |||
2 | Reconstituted Complex | [2] | |||
Interacting Protein Name | Small ribosomal subunit protein eS1 (RPS3A) | Interacting Protein | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | FTE1; MFTL; S3A | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Affinity Capture-MS | [1] | |||
2 | Affinity Capture-Western | [37] | |||
Transcription regulators | [+] 3 Transcription regulators | + | |||
Interacting Target Name | Hypoxia-inducible factor 1 alpha (HIF-1A) | Clinical trial Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | Transcription factor HIF-1; PASD8; PAS domain-containing protein 8; MOP1; Member of PAS protein 1; Hypoxia-inducible transcription factor (HIF)-1; Hypoxia-inducible factor 1-alpha; Hypoxia-inducible factor 1; Hypoxia inducible factor 1; HIF-1-alpha; HIF-1alpha; HIF1-alpha; HIF-1 alpha; HIF1 alpha; Class E basic helix-loop-helix protein 78; bHLHe78; Basic-helix-loop-helix-PAS protein MOP1; ARNT-interacting protein; ARNT interacting protein | ||||
Evidence Score (E-score) | 20 Experimental Evidences | + | |||
1 | Affinity Capture-MS | [19] | |||
2 | Affinity Capture-MS | [20] | |||
3 | Affinity Capture-MS | [23] | |||
4 | Affinity Capture-Western | [45] | |||
5 | Affinity Capture-Western | [46] | |||
6 | Affinity Capture-Western | [47] | |||
7 | Affinity Capture-Western | [48] | |||
8 | Affinity Capture-Western | [49] | |||
9 | Affinity Capture-Western | [25] | |||
10 | Affinity Capture-Western | [50] | |||
11 | Affinity Capture-Western | [51] | |||
12 | Affinity Capture-Western | [52] | |||
13 | Affinity Capture-Western | [53] | |||
14 | Affinity Capture-Western | [54] | |||
15 | Affinity Capture-Western | [55] | |||
16 | Affinity Capture-Western | [56] | |||
17 | Affinity Capture-Western | [57] | |||
18 | Affinity Capture-Western | [58] | |||
19 | Affinity Capture-Western | [59] | |||
20 | Affinity Capture-Western | [20] | |||
Interacting Target Name | Hypoxia-inducible factor 2 alpha (HIF-2A) | Successful Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | PASD2; PAS domain-containing protein 2; MOP2; Member of PAS protein 2; Hypoxia-inducible factor 2-alpha; HLF; HIF-2-alpha; HIF2-alpha; HIF2A; HIF-1-alpha-like factor; EPAS-1; Endothelial PAS domain-containing protein 1; Class E basic helix-loop-helix protein 73; bHLHe73; Basic-helix-loop-helix-PAS protein MOP2 | ||||
Evidence Score (E-score) | 14 Experimental Evidences | + | |||
1 | Affinity Capture-MS | [20] | |||
2 | Affinity Capture-Western | [60] | |||
3 | Affinity Capture-Western | [45] | |||
4 | Affinity Capture-Western | [7] | |||
5 | Affinity Capture-Western | [23] | |||
6 | Affinity Capture-Western | [10] | |||
7 | Affinity Capture-Western | [61] | |||
8 | Affinity Capture-Western | [62] | |||
9 | Affinity Capture-Western | [63] | |||
10 | Affinity Capture-Western | [64] | |||
11 | Affinity Capture-Western | [65] | |||
12 | Affinity Capture-Western | [66] | |||
13 | Reconstituted Complex | [61] | |||
14 | Yeast two hybrid | [67] | |||
Interacting Protein Name | Protein Jade-1 (JADE1) | Interacting Protein | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | PHF17 | ||||
Evidence Score (E-score) | 3 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [68] | |||
2 | Reconstituted Complex | [68] | |||
3 | Yeast two hybrid | [69] | |||
Ubiquitin related proteins | [+] 1 Ubiquitin related proteins | + | |||
Interacting Target Name | Polyubiquitin-C (UBC) | Patented-recorded Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | HMG20; ubiquitin C | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [70] | |||
2 | Reconstituted Complex | [71] | |||
Other proteins | [+] 18 Other proteins | + | |||
Interacting Protein Name | Elongin-C (ELOC) | Interacting Protein | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | SIII; eloC | ||||
Evidence Score (E-score) | 20 Experimental Evidences | + | |||
1 | Affinity Capture-MS | [19] | |||
2 | Affinity Capture-MS | [4] | |||
3 | Affinity Capture-MS | [3] | |||
4 | Affinity Capture-MS | [1] | |||
5 | Affinity Capture-MS | [21] | |||
6 | Affinity Capture-MS | [5] | |||
7 | Affinity Capture-MS | [23] | |||
8 | Affinity Capture-Western | [8] | |||
9 | Affinity Capture-Western | [27] | |||
10 | Affinity Capture-Western | [52] | |||
11 | Affinity Capture-Western | [72] | |||
12 | Affinity Capture-Western | [73] | |||
13 | Affinity Capture-Western | [2] | |||
14 | Affinity Capture-Western | [22] | |||
15 | Affinity Capture-Western | [23] | |||
16 | Affinity Capture-Western | [74] | |||
17 | Affinity Capture-Western | [10] | |||
18 | Affinity Capture-Western | [61] | |||
19 | Affinity Capture-Western | [75] | |||
20 | Affinity Capture-Western | [62] | |||
Interacting Protein Name | Elongin-B (ELOB) | Interacting Protein | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | ELOB; SIII | ||||
Evidence Score (E-score) | 20 Experimental Evidences | + | |||
1 | Affinity Capture-MS | [19] | |||
2 | Affinity Capture-MS | [4] | |||
3 | Affinity Capture-MS | [3] | |||
4 | Affinity Capture-MS | [1] | |||
5 | Affinity Capture-MS | [20] | |||
6 | Affinity Capture-MS | [21] | |||
7 | Affinity Capture-MS | [5] | |||
8 | Affinity Capture-MS | [23] | |||
9 | Affinity Capture-Western | [8] | |||
10 | Affinity Capture-Western | [25] | |||
11 | Affinity Capture-Western | [27] | |||
12 | Affinity Capture-Western | [73] | |||
13 | Affinity Capture-Western | [2] | |||
14 | Affinity Capture-Western | [22] | |||
15 | Affinity Capture-Western | [30] | |||
16 | Affinity Capture-Western | [74] | |||
17 | Affinity Capture-Western | [76] | |||
18 | Affinity Capture-Western | [9] | |||
19 | Affinity Capture-Western | [10] | |||
20 | Affinity Capture-Western | [61] | |||
Interacting Target Name | Fibronectin (FN1) | Clinical trial Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | Ugl-Y3; Ugl-Y2; Ugl-Y1; FN; Cold-insoluble globulin; CIG | ||||
Evidence Score (E-score) | 8 Experimental Evidences | + | |||
1 | Affinity Capture-MS | [1] | |||
2 | Affinity Capture-Western | [77] | |||
3 | Affinity Capture-Western | [27] | |||
4 | Affinity Capture-Western | [78] | |||
5 | Affinity Capture-Western | [75] | |||
6 | Affinity Capture-Western | [79] | |||
7 | Affinity Capture-Western | [80] | |||
8 | Affinity Capture-Western | [81] | |||
Interacting Protein Name | Collagen alpha-2(IV) chain (COL4A2) | Interacting Protein | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | ICH; POREN2 | ||||
Evidence Score (E-score) | 5 Experimental Evidences | + | |||
1 | Affinity Capture-MS | [78] | |||
2 | Affinity Capture-MS | [1] | |||
3 | Affinity Capture-MS | [20] | |||
4 | Affinity Capture-Western | [78] | |||
5 | Affinity Capture-Western | [20] | |||
Interacting Protein Name | Collagen alpha-1(IV) chain (COL4A1) | Interacting Protein | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | BSVD | ||||
Evidence Score (E-score) | 4 Experimental Evidences | + | |||
1 | Affinity Capture-MS | [20] | |||
2 | Affinity Capture-MS | [1] | |||
3 | Affinity Capture-Western | [78] | |||
4 | Affinity Capture-Western | [20] | |||
Interacting Protein Name | Heterogeneous nuclear ribonucleoprotein D0 (HNRNPD) | Interacting Protein | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | AUF1; AUF1A; HNRPD; P37; hnRNPD0 | ||||
Evidence Score (E-score) | 4 Experimental Evidences | + | |||
1 | Affinity Capture-MS | [1] | |||
2 | Affinity Capture-Western | [82] | |||
3 | Biochemical Activity | [82] | |||
4 | Reconstituted Complex | [82] | |||
Interacting Protein Name | Prefoldin subunit 3 (VBP1) | Interacting Protein | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | PFD3; PFDN3; VBP.1 | ||||
Evidence Score (E-score) | 4 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [83] | |||
2 | Affinity Capture-Western | [72] | |||
3 | Yeast two hybrid | [69] | |||
4 | Yeast two hybrid | [83] | |||
Interacting Target Name | Translationally-controlled tumor protein (TPT1) | Discontinued Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | TPT1; TCTP; p23; HRF; Histamine-releasing factor; Fortilin | ||||
Evidence Score (E-score) | 3 Experimental Evidences | + | |||
1 | Affinity Capture-MS | [4] | |||
2 | Affinity Capture-Western | [70] | |||
3 | Reconstituted Complex | [70] | |||
Interacting Target Name | ELAV-like protein 1 (ELAVL1) | Literature-reported Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | HuR; Hu-antigen R | ||||
Evidence Score (E-score) | 3 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [84] | |||
2 | Affinity Capture-Western | [85] | |||
3 | Reconstituted Complex | [84] | |||
Interacting Protein Name | Hepatocellular carcinoma-associated antigen 57 (DNAJA3) | Interacting Protein | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | HCA57; TID1; hTID.1 | ||||
Evidence Score (E-score) | 3 Experimental Evidences | + | |||
1 | Affinity Capture-MS | [1] | |||
2 | Affinity Capture-Western | [86] | |||
3 | Reconstituted Complex | [86] | |||
Interacting Protein Name | Heterogeneous nuclear ribonucleoproteins A2/B1 (HNRNPA2B1) | Interacting Protein | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | HNRPA2B1; hnRNP A2/B1; Heterogeneous nuclear ribonucleoproteins A2/B1 | ||||
Evidence Score (E-score) | 3 Experimental Evidences | + | |||
1 | Affinity Capture-MS | [1] | |||
2 | Affinity Capture-Western | [87] | |||
3 | Affinity Capture-Western | [88] | |||
Interacting Protein Name | T-complex protein 1 subunit alpha (TCP1) | Interacting Protein | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | CCT.alpha; CCT1; CCTa; D6S230E; TCP.1.alpha | ||||
Evidence Score (E-score) | 3 Experimental Evidences | + | |||
1 | Affinity Capture-MS | [20] | |||
2 | Affinity Capture-MS | [1] | |||
3 | Affinity Capture-Western | [57] | |||
Interacting Protein Name | Collagen alpha-3(IV) chain (COL4A3) | Interacting Protein | Interacting Protein Info | ||
UniProt ID | |||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Affinity Capture-MS | [1] | |||
2 | Affinity Capture-Western | [20] | |||
Interacting Protein Name | Heterogeneous nuclear ribonucleoprotein L (HNRNPL) | Interacting Protein | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | HNRPL; hnRNP.L | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Affinity Capture-MS | [1] | |||
2 | Affinity Capture-Western | [87] | |||
Interacting Protein Name | Tubulin alpha-1A chain (TUBA1A) | Interacting Protein | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | B.ALPHA.1; LIS3; TUBA3 | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Affinity Capture-MS | [1] | |||
2 | Affinity Capture-Western | [89] | |||
Interacting Protein Name | T-complex protein 1 subunit epsilon (CCT5) | Interacting Protein | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | CCT.epsilon; CCTE; HEL.S.69; TCP.1.epsilon | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Affinity Capture-MS | [20] | |||
2 | Affinity Capture-MS | [1] | |||
Interacting Protein Name | T-complex protein 1 subunit gamma (CCT3) | Interacting Protein | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | CCT.gamma; CCTG; PIG48; TCP.1.gamma; TRIC5 | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Affinity Capture-MS | [1] | |||
2 | Affinity Capture-Western | [29] | |||
Interacting Protein Name | T-complex protein 1 subunit eta (CCT7) | Interacting Protein | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | CCTETA; CCTH; NIP7.1; TCP1ETA | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Affinity Capture-MS | [20] | |||
2 | Affinity Capture-MS | [1] |
References | Top | ||||
---|---|---|---|---|---|
REF 1 | Proteomic dissection of the von Hippel-Lindau (VHL) interactome. J Proteome Res. 2011 Nov 4;10(11):5175-82. | ||||
REF 2 | The interaction of the von Hippel-Lindau tumor suppressor and heterochromatin protein 1. Arch Biochem Biophys. 2012 Feb 15;518(2):103-10. | ||||
REF 3 | VHL-box and SOCS-box domains determine binding specificity for Cul2-Rbx1 and Cul5-Rbx2 modules of ubiquitin ligases. Genes Dev. 2004 Dec 15;18(24):3055-65. | ||||
REF 4 | Large-scale mapping of human protein-protein interactions by mass spectrometry. Mol Syst Biol. 2007;3:89. | ||||
REF 5 | The von Hippel-Lindau tumor suppressor regulates programmed cell death 5-mediated degradation of Mdm2. Oncogene. 2015 Feb 5;34(6):771-9. | ||||
REF 6 | ASB proteins interact with Cullin5 and Rbx2 to form E3 ubiquitin ligase complexes. FEBS Lett. 2005 Dec 19;579(30):6796-802. | ||||
REF 7 | DCNL1 functions as a substrate sensor and activator of cullin 2-RING ligase. Mol Cell Biol. 2013 Apr;33(8):1621-31. | ||||
REF 8 | An ID2-dependent mechanism for VHL inactivation in cancer. Nature. 2016 Jan 14;529(7585):172-7. | ||||
REF 9 | A molecular basis for stabilization of the von Hippel-Lindau (VHL) tumor suppressor protein by components of the VHL ubiquitin ligase. J Biol Chem. 2002 Aug 16;277(33):30388-93. | ||||
REF 10 | von Hippel-Lindau protein binds hyperphosphorylated large subunit of RNA polymerase II through a proline hydroxylation motif and targets it for ubiquitination. Proc Natl Acad Sci U S A. 2003 Mar 4;100(5):2706-11. | ||||
REF 11 | Renal cell carcinoma risk in type 2 von Hippel-Lindau disease correlates with defects in pVHL stability and HIF-1alpha interactions. Oncogene. 2006 Jan 19;25(3):370-7. | ||||
REF 12 | Analysis of Nedd8-associated polypeptides: a model for deciphering the pathway for ubiquitin-like modifications. Biochemistry. 2006 Mar 7;45(9):3014-9. | ||||
REF 13 | PIAS4 is an activator of hypoxia signalling via VHL suppression during growth of pancreatic cancer cells. Br J Cancer. 2013 Oct 1;109(7):1795-804. | ||||
REF 14 | Hypoxia inactivates the VHL tumor suppressor through PIASy-mediated SUMO modification. PLoS One. 2010 Mar 16;5(3):e9720. | ||||
REF 15 | pVHL-mediated transcriptional repression of c-Myc by recruitment of histone deacetylases. Mol Cells. 2012 Feb;33(2):195-201. | ||||
REF 16 | FIH-1: a novel protein that interacts with HIF-1alpha and VHL to mediate repression of HIF-1 transcriptional activity. Genes Dev. 2001 Oct 15;15(20):2675-86. | ||||
REF 17 | Characterization of the VHL tumor suppressor gene product: localization, complex formation, and the effect of natural inactivating mutations. Proc Natl Acad Sci U S A. 1995 Jul 3;92(14):6459-63. | ||||
REF 18 | Isoform-specific interactions of the von Hippel-Lindau tumor suppressor protein. Sci Rep. 2015 Jul 27;5:12605. | ||||
REF 19 | Architecture of the human interactome defines protein communities and disease networks. Nature. 2017 May 25;545(7655):505-509. | ||||
REF 20 | Interaction of hydroxylated collagen IV with the von hippel-lindau tumor suppressor. J Biol Chem. 2007 May 4;282(18):13264-9. | ||||
REF 21 | Characterization of Cullin-box sequences that direct recruitment of Cul2-Rbx1 and Cul5-Rbx2 modules to Elongin BC-based ubiquitin ligases. J Biol Chem. 2008 Mar 21;283(12):8005-13. | ||||
REF 22 | The von Hippel-Lindau tumor-suppressor gene product forms a stable complex with human CUL-2, a member of the Cdc53 family of proteins. Proc Natl Acad Sci U S A. 1997 Mar 18;94(6):2156-61. | ||||
REF 23 | Interaction between von Hippel-Lindau Protein and Fatty Acid Synthase Modulates Hypoxia Target Gene Expression. Sci Rep. 2017 Aug 3;7(1):7190. | ||||
REF 24 | Substrate-mediated regulation of cullin neddylation. J Biol Chem. 2007 Jun 8;282(23):17032-40. | ||||
REF 25 | Oxygen-independent degradation of HIF-alpha via bioengineered VHL tumour suppressor complex. EMBO Mol Med. 2009 Apr;1(1):66-78. | ||||
REF 26 | Role of the NEDD8 modification of Cul2 in the sequential activation of ECV complex. Neoplasia. 2006 Nov;8(11):956-63. | ||||
REF 27 | NEDD8 acts as a 'molecular switch' defining the functional selectivity of VHL. EMBO Rep. 2008 May;9(5):486-91. | ||||
REF 28 | Dynamic HIF1A regulation during human placental development. Biol Reprod. 2006 Jul;75(1):112-21. | ||||
REF 29 | Diverse effects of mutations in exon II of the von Hippel-Lindau (VHL) tumor suppressor gene on the interaction of pVHL with the cytosolic chaperonin and pVHL-dependent ubiquitin ligase activity. Mol Cell Biol. 2002 Mar;22(6):1947-60. | ||||
REF 30 | Synthetic peptides define critical contacts between elongin C, elongin B, and the von Hippel-Lindau protein. J Clin Invest. 1999 Dec;104(11):1583-91. | ||||
REF 31 | The von Hippel-Lindau tumor suppressor protein and Egl-9-Type proline hydroxylases regulate the large subunit of RNA polymerase II in response to oxidative stress. Mol Cell Biol. 2008 Apr;28(8):2701-17. | ||||
REF 32 | Identification of pVHL as a novel substrate for Aurora-A in clear cell renal cell carcinoma (ccRCC). PLoS One. 2013 Jun 13;8(6):e67071. | ||||
REF 33 | Ubiquitination and regulation of AURKA identifies a hypoxia-independent E3 ligase activity of VHL. Oncogene. 2017 Jun 15;36(24):3450-3463. | ||||
REF 34 | Tumor suppression by the von Hippel-Lindau protein requires phosphorylation of the acidic domain. J Biol Chem. 2005 Jun 10;280(23):22205-11. | ||||
REF 35 | Von Hippel-Lindau regulates interleukin-32 stability in ovarian cancer cells. Oncotarget. 2017 Jul 17;8(41):69833-69846. | ||||
REF 36 | The von Hippel-Lindau tumour-suppressor protein interaction with protein kinase Cdelta. Biochem J. 2006 Jul 1;397(1):109-20. | ||||
REF 37 | The von Hippel-Lindau protein pVHL inhibits ribosome biogenesis and protein synthesis. J Biol Chem. 2013 Jun 7;288(23):16588-97. | ||||
REF 38 | Regulation of the transcriptional activation of the androgen receptor by the UXT-binding protein VHL. Biochem J. 2013 Nov 15;456(1):55-66. | ||||
REF 39 | The von hippel-lindau protein suppresses androgen receptor activity. Mol Endocrinol. 2014 Feb;28(2):239-48. | ||||
REF 40 | The LIMD1 protein bridges an association between the prolyl hydroxylases and VHL to repress HIF-1 activity. Nat Cell Biol. 2012 Jan 29;14(2):201-8. | ||||
REF 41 | RHOBTB3 promotes proteasomal degradation of HIF through facilitating hydroxylation and suppresses the Warburg effect. Cell Res. 2015 Sep;25(9):1025-42. | ||||
REF 42 | Ubiquitination of a novel deubiquitinating enzyme requires direct binding to von Hippel-Lindau tumor suppressor protein. J Biol Chem. 2002 Feb 15;277(7):4656-62. | ||||
REF 43 | Deubiquitinating enzyme USP33/VDU1 is required for Slit signaling in inhibiting breast cancer cell migration. Proc Natl Acad Sci U S A. 2009 Aug 25;106(34):14530-5. | ||||
REF 44 | p53 stabilization and transactivation by a von Hippel-Lindau protein. Mol Cell. 2006 May 5;22(3):395-405. | ||||
REF 45 | The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis. Nature. 1999 May 20;399(6733):271-5. | ||||
REF 46 | pVHL suppresses kinase activity of Akt in a proline-hydroxylation-dependent manner. Science. 2016 Aug 26;353(6302):929-32. | ||||
REF 47 | von Hippel-Lindau protein adjusts oxygen sensing of the FIH asparaginyl hydroxylase. Int J Biochem Cell Biol. 2011 May;43(5):795-804. | ||||
REF 48 | Phospholipase D1 protein coordinates dynamic assembly of HIF-1-PHD-VHL to regulate HIF-1 stability. Oncotarget. 2014 Dec 15;5(23):11857-72. | ||||
REF 49 | Phospholipase D2 promotes degradation of hypoxia-inducible factor-1 independent of lipase activity. Exp Mol Med. 2015 Nov 27;47:e196. | ||||
REF 50 | COMMD1 disrupts HIF-1alpha/beta dimerization and inhibits human tumor cell invasion. J Clin Invest. 2010 Jun;120(6):2119-30. | ||||
REF 51 | Role of the C-terminal alpha-helical domain of the von Hippel-Lindau protein in its E3 ubiquitin ligase activity. Oncogene. 2004 Mar 25;23(13):2315-23. | ||||
REF 52 | Spermidine/spermine-N1-acetyltransferase 2 is an essential component of the ubiquitin ligase complex that regulates hypoxia-inducible factor 1alpha. J Biol Chem. 2007 Aug 10;282(32):23572-80. | ||||
REF 53 | STAT3 inhibits the degradation of HIF-1alpha by pVHL-mediated ubiquitination. Exp Mol Med. 2008 Oct 31;40(5):479-85. | ||||
REF 54 | Activation of HIF1alpha ubiquitination by a reconstituted von Hippel-Lindau (VHL) tumor suppressor complex. Proc Natl Acad Sci U S A. 2000 Sep 12;97(19):10430-5. | ||||
REF 55 | Loss of Mel-18 induces tumor angiogenesis through enhancing the activity and expression of HIF-1 mediated by the PTEN/PI3K/Akt pathway. Oncogene. 2011 Nov 10;30(45):4578-89. | ||||
REF 56 | Reciprocal regulation of HIF-1 and lincRNA-p21 modulates the Warburg effect. Mol Cell. 2014 Jan 9;53(1):88-100. | ||||
REF 57 | Proteostasis modulators prolong missense VHL protein activity and halt tumor progression. Cell Rep. 2013 Jan 31;3(1):52-9. | ||||
REF 58 | VDUP1 mediates nuclear export of HIF1alpha via CRM1-dependent pathway. Biochim Biophys Acta. 2008 May;1783(5):838-48. | ||||
REF 59 | HIF-1alpha binding to VHL is regulated by stimulus-sensitive proline hydroxylation. Proc Natl Acad Sci U S A. 2001 Aug 14;98(17):9630-5. | ||||
REF 60 | Cancer-causing mutations in a novel transcription-dependent nuclear export motif of VHL abrogate oxygen-dependent degradation of hypoxia-inducible factor. Mol Cell Biol. 2008 Jan;28(1):302-14. | ||||
REF 61 | Hypoxia inducible factor-alpha binding and ubiquitylation by the von Hippel-Lindau tumor suppressor protein. J Biol Chem. 2000 Aug 18;275(33):25733-41. | ||||
REF 62 | Inactivation of VHL by tumorigenic mutations that disrupt dynamic coupling of the pVHL.hypoxia-inducible transcription factor-1alpha complex. J Biol Chem. 2005 Mar 4;280(9):7985-96. | ||||
REF 63 | Loss of JAK2 regulation via a heterodimeric VHL-SOCS1 E3 ubiquitin ligase underlies Chuvash polycythemia. Nat Med. 2011 Jun 19;17(7):845-53. | ||||
REF 64 | Contrasting effects on HIF-1alpha regulation by disease-causing pVHL mutations correlate with patterns of tumourigenesis in von Hippel-Lindau disease. Hum Mol Genet. 2001 May 1;10(10):1029-38. | ||||
REF 65 | HIFalpha targeted for VHL-mediated destruction by proline hydroxylation: implications for O2 sensing. Science. 2001 Apr 20;292(5516):464-8. | ||||
REF 66 | RSUME inhibits VHL and regulates its tumor suppressor function. Oncogene. 2015 Sep 10;34(37):4855-66. | ||||
REF 67 | A yeast two-hybrid system reconstituting substrate recognition of the von Hippel-Lindau tumor suppressor protein. Nucleic Acids Res. 2007;35(21):e142. | ||||
REF 68 | Tumor suppressor von Hippel-Lindau (VHL) stabilization of Jade-1 protein occurs through plant homeodomains and is VHL mutation dependent. Cancer Res. 2004 Feb 15;64(4):1278-86. | ||||
REF 69 | The von Hippel-Lindau tumor suppressor stabilizes novel plant homeodomain protein Jade-1. J Biol Chem. 2002 Oct 18;277(42):39887-98. | ||||
REF 70 | TCTP increases stability of hypoxia-inducible factor 1 by interaction with and degradation of the tumour suppressor VHL. Biol Cell. 2013 May;105(5):208-218. | ||||
REF 71 | The von Hippel-Lindau tumor suppressor protein is a component of an E3 ubiquitin-protein ligase activity. Genes Dev. 1999 Jul 15;13(14):1822-33. | ||||
REF 72 | VBP1 represses cancer metastasis by enhancing HIF-1 degradation induced by pVHL. FEBS J. 2018 Jan;285(1):115-126. | ||||
REF 73 | Regulation of receptor for activated C kinase 1 protein by the von Hippel-Lindau tumor suppressor in IGF-I-induced renal carcinoma cell invasiveness. Oncogene. 2011 Feb 3;30(5):535-47. | ||||
REF 74 | VHL type 2B mutations retain VBC complex form and function. PLoS One. 2008;3(11):e3801. | ||||
REF 75 | pVHL modification by NEDD8 is required for fibronectin matrix assembly and suppression of tumor development. Mol Cell Biol. 2004 Apr;24(8):3251-61. | ||||
REF 76 | Association of SAP130/SF3b-3 with Cullin-RING ubiquitin ligase complexes and its regulation by the COP9 signalosome. BMC Biochem. 2008 Jan 3;9:1. | ||||
REF 77 | The von Hippel-Lindau tumor suppressor protein is required for proper assembly of an extracellular fibronectin matrix. Mol Cell. 1998 Jun;1(7):959-68. | ||||
REF 78 | Collagen matrix assembly is driven by the interaction of von Hippel-Lindau tumor suppressor protein with hydroxylated collagen IV alpha 2. Oncogene. 2008 Feb 7;27(7):1004-12. | ||||
REF 79 | Role of exon 2-encoded beta -domain of the von Hippel-Lindau tumor suppressor protein. J Biol Chem. 2001 Jan 12;276(2):1407-16. | ||||
REF 80 | pVHL19 is a biologically active product of the von Hippel-Lindau gene arising from internal translation initiation. Proc Natl Acad Sci U S A. 1998 Sep 29;95(20):11661-6. | ||||
REF 81 | Downregulation of integrins by von Hippel-Lindau (VHL) tumor suppressor protein is independent of VHL-directed hypoxia-inducible factor alpha degradation. Biochem Cell Biol. 2008 Jun;86(3):227-34. | ||||
REF 82 | Association of the von Hippel-Lindau protein with AUF1 and posttranscriptional regulation of VEGFA mRNA. Mol Cancer Res. 2012 Jan;10(1):108-20. | ||||
REF 83 | Identification of a novel protein (VBP-1) binding to the von Hippel-Lindau (VHL) tumor suppressor gene product. Cancer Res. 1996 Jul 1;56(13):2881-5. | ||||
REF 84 | Role of elongin-binding domain of von Hippel Lindau gene product on HuR-mediated VPF/VEGF mRNA stability in renal cell carcinoma. Oncogene. 2005 Nov 24;24(53):7850-8. | ||||
REF 85 | The VHL tumor suppressor inhibits expression of the IGF1R and its loss induces IGF1R upregulation in human clear cell renal carcinoma. Oncogene. 2007 Oct 4;26(45):6499-508. | ||||
REF 86 | Tid-1 interacts with the von Hippel-Lindau protein and modulates angiogenesis by destabilization of HIF-1alpha. Cancer Res. 2005 Apr 1;65(7):2520-5. | ||||
REF 87 | The HILDA complex coordinates a conditional switch in the 3'-untranslated region of the VEGFA mRNA. PLoS Biol. 2013;11(8):e1001635. | ||||
REF 88 | A novel VHL isoform inhibits Warburg effect via modulation of PKM splicing. Tumour Biol. 2016 Oct;37(10):13649-13657. | ||||
REF 89 | Regulation of microtubule stability by the von Hippel-Lindau tumour suppressor protein pVHL. Nat Cell Biol. 2003 Jan;5(1):64-70. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.